Saw Palmetto Extract

Saw palmetto materials should not be compared by product name alone. A dry extract powder and a lipid/oil extract can differ substantially in composition, assay basis, processing behaviour and suitable dosage form.

Parameter	What buyers should confirm
Botanical identity	Accepted botanical name, fruit part and identity method
Total fatty acids	Declared assay, calculation basis and GC method where applicable
Sterols	Profile or marker requirements where relevant to the selected grade
Extract format	Dry powder, lipid extract or oil; extraction process and physical form
Full composition	Carriers, encapsulation aids, antioxidants or other excipients

A high numerical fatty-acid value does not by itself establish that two grades are equivalent. Compare identity, chromatographic profile, method, extract basis and full composition.

Potential applications: Capsules, tablets, softgels and other pharmaceutical or complementary-medicine development, subject to the selected grade and finished-product pathway.

Formulation considerations: Lipid extracts may suit softgel or oil-based systems, while dry extracts may require carrier, flow and dispersion review for capsules or tablets. Confirm odour, colour, oxidation control, compatibility with excipients and finished-product stability.

Key development checks: Assay and identity methods, batch consistency, peroxide or oxidation indicators where relevant, contaminants, residual solvents, microbiology, particle size for powders and packaging protection for lipid grades.

Serenoa repens appears in Australian therapeutic goods records, but this does not mean every saw palmetto grade, dose, dosage form, indication or claim is automatically acceptable. The exact ingredient terminology, preparation, restrictions, finished-product classification and current TGA requirements must be checked for the proposed medicine.

This ingredient page is not evidence for treating benign prostatic hyperplasia, kidney disease, cystitis, orchitis, hair loss or any other condition. Therapeutic indications require an appropriate regulatory pathway and evidence for the finished product.

Depending on the selected grade, available support may include a current specification, representative or batch COA, TDS, SDS, botanical-identity information, fatty-acid and sterol data, chromatographic information, extraction-solvent and carrier declarations, residual-solvent results, pesticides, heavy metals and microbiological limits.

For a useful sample or bulk enquiry, provide the intended dosage form, target fatty-acid or sterol requirements, preferred extract format, analytical method, trial quantity, annual forecast, destination market and required documents.

For procurement review, see How to Read a Certificate of Analysis for Herbal Extracts and How to Choose a Plant Extract Supplier in Australia.

Request specification, COA or sample

Send bulk enquiry

Is saw palmetto powder the same as a lipid extract?
No. The physical form, manufacturing process, fatty-acid concentration, excipients and formulation behaviour can differ. Define the required grade before comparing quotations.

What should be compared between suppliers?
Compare botanical identity, plant part, extract format, assay and method, fatty-acid and sterol profile, full composition, residual solvents, contaminant limits and batch documentation.

Does an ARTG-listed product prove every raw material is acceptable?
No. It confirms that a particular finished product is entered in the register. The proposed raw material, preparation, dose, claims and finished formulation still require separate assessment.

What information is needed for a sample?
Provide the target format, specification, dosage form, intended market, trial quantity and documentation requirements.